ERBB2 and breast carcinoma: Our aim was to establish a breast cancer cell line with HER2 overexpression and a high percentage of BCSC subpopulations to assess the effect of combined cell surface HER2-targeting and BCSC-specific transcriptional targeting of our multi-targeted nanosystem.